Atlas Trials

Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma

Clinical trial NCT06314334 · RECRUITING

Trial details

NCT number
NCT06314334
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Start date
2024-03-04
Primary completion
2026-12-30
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.